Genotype-guided fluoropyrimidine dosing: ready for implementation
- PMID: 30348539
- DOI: 10.1016/S1470-2045(18)30744-7
Genotype-guided fluoropyrimidine dosing: ready for implementation
Comment on
-
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.Lancet Oncol. 2018 Nov;19(11):1459-1467. doi: 10.1016/S1470-2045(18)30686-7. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348537
Similar articles
-
Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.J Cardiovasc Pharmacol Ther. 2015 Jul;20(4):387-94. doi: 10.1177/1074248414565666. Epub 2015 Jan 8. J Cardiovasc Pharmacol Ther. 2015. PMID: 25575537
-
Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.J Clin Oncol. 2016 Jan 20;34(3):227-34. doi: 10.1200/JCO.2015.63.1325. Epub 2015 Nov 16. J Clin Oncol. 2016. PMID: 26573078 Clinical Trial.
-
Genotype-guided coumarin dosing: where are we now and where do we need to go next?Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):509-22. doi: 10.1517/17425255.2015.1004053. Epub 2015 Jan 16. Expert Opin Drug Metab Toxicol. 2015. PMID: 25595525 Review.
-
Warfarin Dosing According to the Genotype-guided Algorithm is Most Beneficial in Patients With Atrial Fibrillation: A Randomized Parallel Group Trial.Ther Drug Monit. 2018 Jun;40(3):362-368. doi: 10.1097/FTD.0000000000000501. Ther Drug Monit. 2018. PMID: 29494423 Clinical Trial.
-
Genotype-guided dosing versus conventional dosing of warfarin: A meta-analysis of 15 randomized controlled trials.J Clin Pharm Ther. 2019 Apr;44(2):197-208. doi: 10.1111/jcpt.12782. Epub 2018 Dec 28. J Clin Pharm Ther. 2019. PMID: 30593674 Review.
Cited by
-
Colorectal Cancer Biomarkers in the Era of Personalized Medicine.J Pers Med. 2019 Jan 14;9(1):3. doi: 10.3390/jpm9010003. J Pers Med. 2019. PMID: 30646508 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical